S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 241 to 298 of 298

Issue Date	Title / Author(s) / Citation	File
2018-02	Use of olaparib in patients with advanced gastric cancer Bang, Yung-Jue The Lancet Oncology, Vol.19 No.2, pp.E76-E76	DOI
2018-02	Phase I pharmacokinetic study of nivolumab in Korean patients with advanced solid tumors Lee, Keun-Wook; Lee, Dae Ho; Kang, Jin Hyoung; Park, Joon Oh; Kim, Se Hyun; Hong, Yong Sang; Kim, Seung Tae; Oh, Do-Youn; Bang, Yung-Jue Oncologist, Vol.23 No.2, pp.155-e17	DOI
2018-03	Long-term trastuzumab (Herceptin (R)) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer Mueller, Volkmar; Clemens, Michael; Jassem, Jacek; Al-Sakaff, Nedal; Auclair, Petra; Nuesch, Eveline; Holloway, Debbie; Shing, Mona; Bang, Yung-Jue BMC Cancer, Vol.18, p. 295	view file DOI
2018-03	Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012 Tahara, Makoto; Muro, Kei; Hasegawa, Yasuhisa; Chung, Hyun Cheol; Lin, Chia-Chi; Keam, Bhumsuk; Takahashi, Kenichi; Cheng, Jonathan D.; Bang, Yung-Jue Cancer Science, Vol.109 No.3, pp.771-776	DOI
2018-04	TAK-264 (MLN0264) in previously treated Asian patients with advanced gastrointestinal carcinoma expressing guanylyl cyclase C: Results from an open-label, non-randomized phase 1 study Bang, Yung-Jue; Takano, Toshimi; Lin, Chia-Chi; Fasanmade, Adedigbo; Yang, Huyuan; Danaee, Hadi; Asato, Takayuki; Kalebic, Thea; Wang, Hui; Doi, Toshihiko Cancer Research and Treatment, Vol.50 No.2, pp.398-404	DOI
2018-05	Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial Fuchs, Charles S.; Doi, Toshihiko; Jang, Raymond W.; Muro, Kei; Satoh, Taroh; Machado, Manuela; Sun, Weijing; Jalal, Shadia I.; Shah, Manish A.; Metges, Jean-Phillipe; Garrido, Marcelo; Golan, Talia; Mandala, Mario; Wainberg, Zev A.; Catenacci, Daniel V.; Ohtsu, Atsushi; Shitara, Kohei; Geva, Ravit; Bleeker, Jonathan; Ko, Andrew H.; Ku, Geoffrey; Philip, Philip; Enzinger, Peter C.; Bang, Yung-Jue; Levitan, Diane; Wang, Jiangdian; Rosales, Minori; Dalal, Rita P.; Yoon, Harry H. JAMA oncology, Vol.4 No.5, p. e180013	DOI
2018-05	Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives Taieb, Julien; Moehler, Markus; Boku, Narikazu; Ajani, Jaffer A.; Ruiz, Eduardo Yanez; Ryu, Min-Hee; Guenther, Silke; Chand, Vikram; Bang, Yung-Jue Cancer Treatment Reviews, Vol.66, pp.104-113	DOI
2018-07	Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): A randomised, open-label, controlled, phase 3 trial Shitara, Kohei; Ozguroglu, Mustafa; Bang, Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro, Lorenzo; Olesinski, Tomasz; Caglevic, Christian; Chung, Hyun C.; Muro, Kei; Goekkurt, Eray; Mansoor, Wasat; McDermott, Raymond S.; Shacham-Shmueli, Einat; Chen, Xinqun; Mayo, Carlos; Kang, S. Peter; Ohtsu, Atsushi; Fuchs, Charles S. The Lancet, Vol.392 No.10142, pp.123-133	DOI
2018-10	Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: Primary analysis of JAVELIN Gastric 300 Bang, Y. -J.; Ruiz, E. Yanez; Van Cutsem, E.; Lee, K. -W.; Wyrwicz, L.; Schenker, M.; Alsina, M.; Ryu, M. -H.; Chung, H. -C.; Evesque, L.; Al-Batran, S. -E.; Park, S. H.; Lichinitser, M.; Boku, N.; Moehler, M. H.; Hong, J.; Xiong, H.; Hallwachs, R.; Conti, I.; Taieb, J. Annals of Oncology, Vol.29 No.10, pp.2052-2060	DOI
2019-02	Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design Moehler, Markus; Ryu, Min-Hee; Dvorkin, Mikhail; Lee, Keun-Wook; Coskun, Hasan S.; Wong, Rachel; Chung, Hyun C.; Poltoratsky, Artem; Tsuji, Akihito; Yen, Chia Jui; Muntean, Alina S.; Le Sourd, Samuel; Vaccaro, Gina M.; Overton, Lindsay; Boku, Narikazu; Wainberg, Zev A.; Patel, Manish; Sharma, Maitreyi; Xiong, Huiling; Conti, Ilaria; Taieb, Julien; Bang, Yung-Jue Future Oncology, Vol.15 No.6, pp.567-577	DOI
2019-02	T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028 Ott, Patrick A.; Bang, Yung-Jue; Piha-Paul, Sarina A.; Razak, Albiruni R. Abdul; Bennouna, Jaafar; Soria, Jean-Charles; Rugo, Hope S.; Cohen, Roger B.; O'Neil, Bert H.; Mehnert, Janice M.; Lopez, Juanita; Doi, Toshihiko; van Brummelen, Emilie M. J.; Cristescu, Razvan; Yang, Ping; Emancipator, Kenneth; Stein, Karen; Ayers, Mark; Joe, Andrew K.; Lunceford, Jared K. Journal of Clinical Oncology, Vol.37 No.4, pp.318-327	DOI
2019-02	A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer Bang, Y. -J.; Kang, Y. -K.; Ng, M.; Chung, H. C.; Wainberg, Z. A.; Gendreau, S.; Chan, W. Y.; Xu, N.; Maslyar, D.; Meng, R.; Chau, I; Ajani, J. A. European Journal of Cancer, Vol.108, pp.17-24	DOI
2019-02	SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer van den Boom, Hector G.; Abu-Hanna, Ameen; ter Veer, Emil; van Kleef, Jessy Joy; Lordick, Florian; Stahl, Michael; Ajani, Jaffer A.; Guimbaud, Rosine; Park, Se Hoon; Dutton, Susan J.; Bang, Yung-Jue; Boku, Narikazu; Mohammad, Nadia Haj; Sprangers, Mirjam A. G.; Verhoeven, Rob H. A.; Zwinderman, Aeilko H.; van Oijen, Martijn G. H.; van Laarhoven, Hanneke W. M. Cancers, Vol.11 No.2, p. 187	DOI
2019-03	KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles S.; Ohtsu, Atsushi; Tabernero, Josep; Ilson, David H.; Hyung, Woo Jin; Strong, Vivian E.; Goetze, Thorsten Oliver; Yoshikawa, Takaki; Tang, Laura H.; Hwang, Peggy May Tan; Webb, Nancy; Adelberg, David; Shitara, Kohei Future Oncology, Vol.15 No.9, pp.943-952	DOI
2019-04	Dynamics of soluble programmed death-ligand 1 (SPDL1) during chemotherapy and its prognostic implications in cancer patients: Biomarker development in immuno-oncology Ha, Hyerim; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji-Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Cancer Research and Treatment, Vol.51 No.2, pp.832-840	DOI
2019-05	Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancer Kim, Hee Sung; Hwang, In Gyu; Min, Hye Young; Bang, Yung-Jue; Kim, Woo Ho Oncology Letters, Vol.17 No.5, pp.4383-4392	DOI
2019-06	Phase I study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) administered with PD-L1 inhibitor (atezolizumab) in advanced solid tumors Jung, Kyung Hae; LoRusso, Patricia; Burris, Howard; Gordon, Michael; Bang, Yung-Jue; Hellmann, Matthew D.; Cervantes, Andres; Ochoa de Olza, Maria; Marabelle, Aurelien; Hodi, Stephen; Ahn, Myung-Ju; Emens, Leisha A.; Barlesi, Fabrice; Hamid, Omid; Calvo, Emiliano; McDermott, David; Soliman, Hatem; Rhee, Ina; Lin, Ray; Pourmohamad, Tony; Suchomel, Julia; Tsuhako, Amy; Morrissey, Kari; Mahrus, Sami; Morley, Roland; Pirzkall, Andrea; Davis, S. Lindsey Clinical Cancer Research, Vol.25 No.11, pp.3220-3228	DOI
2019-07	Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study Bang, Yung-Jue; Kang, Yoon-Koo; Catenacci, Daniel V.; Muro, Kei; Fuchs, Charles S.; Geva, Ravit; Hara, Hiroki; Golan, Talia; Garrido, Marcelo; Jalal, Shadia I.; Borg, Christophe; Doi, Toshihiko; Yoon, Harry H.; Savage, Mary J.; Wang, Jiangdian; Dalal, Rita P.; Shah, Sukrut; Wainberg, Zev A.; Chung, Hyun Cheol Gastric Cancer, Vol.22 No.4, pp.828-837	DOI
2019-07	Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors Hellmann, M. D.; Kim, T. -W.; Lee, C. B.; Goh, B-C; Miller, W. H., Jr.; Oh, D. -Y.; Jamal, R.; Chee, C. -E.; Chow, L. Q. M.; Gainor, J. F.; Desai, J.; Solomon, B. J.; Das Thakur, M.; Pitcher, B.; Foster, P.; Hernandez, G.; Wongchenko, M. J.; Cha, E.; Bang, Y. -J.; Siu, L. L.; Bendell, J. Annals of Oncology, Vol.30 No.7, pp.1134-1142	DOI
2019-07	Therapeutic targeting of the DNA damage response using an ATR inhibitor in biliary tract cancer Nam, Ah-Rong; Jin, Mei Hua; Park, Ji Eun; Bang, Ju-Hee; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.51 No.3, pp.1167-1179	DOI
2019-07	Jab1 silencing inhibits proliferation and sensitizes to cisplatin in biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.51 No.3, pp.886-900	DOI
2019-07	Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001 Shaw, Alice Tsang; Riely, Gregory J.; Bang, Yung-Jue; Kim, Dong-Wan; Camidge, David Ross; Solomon, Benjamin J.; Varella-Garcia, Marileila; Iafrate, Anthony John; Shapiro, Geoffrey I.; Usari, Tiziana; Wang, S. C.; Wilner, Keith. D.; Clark, Jeffrey W.; Ou, Sai Hong Ignatius Annals of Oncology, Vol.30 No.7, pp.1121-1126	DOI
2019-08	A First-in-Human Phase I Study of GC1118, a Novel Anti-Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors Oh, Do-Youn; Lee, Keun-Wook; Han, Sae-Won; Kim, Jin Won; Shin, Jung-Won; Jo, Seong-Jin; Won, Jonghwa; Hahn, Seokyung; Lee, Howard; Kim, Woo Ho; Bang, Yung-Jue Oncologist, Vol.24 No.8, pp.1037-e636-+	DOI
2019-08	Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: Phase Ib study Kim, Jin Won; Lee, Kyung-Hun; Kim, Ji-Won; Suh, Koung Jin; Nam, Ah-Rong; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn British Journal of Cancer, Vol.121 No.4, pp.332-339	DOI
2019-09	GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer Park, Ji Eun; Jin, Mei Hua; Hur, Minkyu; Nam, Ah-Rong; Bang, Ju-Hee; Won, Jonghwa; Oh, Do-Youn; Bang, Yung-Jue Gastric Cancer, Vol.22 No.5, pp.932-940	DOI
2019-11	A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer Kim, Tae-Yong; Han, Hye Sook; Lee, Keun-Wook; Zang, Dae Young; Rha, Sun Young; Park, Young lee; Kim, Jin-Soo; Lee, Kyung-Hun; Park, Se Hoon; Song, Eun-Kee; Jung, Soo-A; Lee, NaMi; Kim, Yeul Hong; Cho, Jae Yong; Bang, Yung-Jue Gastric Cancer, Vol.22 No.6, pp.1206-1214	DOI
2019-11	Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysis Park, Changhee; Keam, Bhumsuk; Yoon, Soon Ho; Ock, Chan-Young; Choi, Sun Mi; Kim, Miso; Park, Young Sik; Kim, Tae Min; Oh, Do-Youn; Kim, Dong-Wan; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue Esmo Open, Vol.4 No.6, p. e000575	DOI
2019-12	Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer Park, Hyunkyung; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn Scientific Reports, Vol.9 No.1, p. 11131	DOI
2020-01	Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer Jin, Mei Hua; Nam, Ah-Rong; Park, Ji Eun; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn Cancer Research and Treatment, Vol.52 No.1, pp.149-166	view file DOI
2020-01	Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study Yoo, Shin Hye; Kang, Seo Young; Cheon, Gi Jeong; Oh, Do-Youn; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.61 No.1, pp.33-39	DOI
2020-01	Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study Marabelle, Aurelien; Le, Dung T.; Ascierto, Paolo A.; Di Giacomo, Anna Maria; De Jesus-Acosta, Ana; Delord, Jean-Pierre; Geva, Ravit; Gottfried, Maya; Penel, Nicolas; Hansen, Aaron R.; Piha-Paul, Sarina A.; Doi, Toshihiko; Gao, Bo; Chung, Hyun Cheol; Lopez-Martin, Jose; Bang, Yung-Jue; Frommer, Ronnie Shapira; Shah, Manisha; Ghori, Razi; Joe, Andrew K.; Pruitt, Scott K.; Diaz, Luis A., Jr. Journal of Clinical Oncology, Vol.38 No.1, pp.1-10	DOI
2020-01	HER2-targeted therapies - a role beyond breast cancer Oh, Do-Youn; Bang, Yung-Jue Nature Reviews Clinical Oncology, Vol.17 No.1, pp.33-48	DOI
2020-02	Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts Bang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck; Bauer, Todd M.; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette Cancer Science, Vol.111 No.2, pp.536-547	DOI
2020-02	Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study Bang, Yung-Jue; Li, Chung-Pin; Lee, Kyung-Hun; Chiu, Chang-Fang; Park, Joon Oh; Shan, Yan-Shen; Kim, Jun Suk; Chen, Jen-Shi; Shim, Hyun-Jeong; Rau, Kun-Ming; Choi, Hye Jin; Oh, Do-Youn; Belanger, Bruce; Chen, Li-Tzong Cancer Science, Vol.111 No.2, pp.513-527	view file DOI
2020-02	Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study Kato, Hidenori; de Souza, Paul; Kim, Sang-We; Lickliter, Jason D.; Naito, Yoichi; Park, Keunchil; Kumar, Sanjeev; Mugundu, Ganesh M.; Bang, Yung-Jue Targeted Oncology, Vol.15 No.1, pp.75-84	DOI
2020-02	Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma Kelly, Ronan J.; Lee, Jeeyun; Bang, Yung-Jue; Almhanna, Khaldoun; Blum-Murphy, Mariela; Catenacci, Daniel V. T.; Hyun Cheol Chung; Wainberg, Zev A.; Gibson, Michael K.; Lee, Keun-Wook; Bendell, Johanna C.; Denlinger, Crystal S.; Chee, Cheng Ean; Omori, Takeshi; Leidner, Rom; Lenz, Heinz-Josef; Chao, Yee; Rebelatto, Marlon C.; Brohawn, Philip Z.; He, Peng; McDevitt, Jennifer; Sheth, Siddharth; Englert, Judson M.; Ku, Geoffrey Y. Clinical Cancer Research, Vol.26 No.4, pp.846-854	DOI
2020-06	Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer Shitara, Kohei; Bang, Yung-Jue; Iwasa, Satoru; Sugimoto, Naotoshi; Ryu, Min-Hee; Sakai, Daisuke; Chung, Hyun-Cheol; Kawakami, Hisato; Yabusaki, Hiroshi; Lee, Jeeyun; Saito, Kaku; Kawaguchi, Yoshinori; Kamio, Takahiro; Kojima, Akihito; Sugihara, Masahiro; Yamaguchi, Kensei New England Journal of Medicine, Vol.382 No.25, pp.2419-2430	DOI
2020-07	Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer Nam, Ah-Rong; Jin, Mie-Hua; Bang, Ju-Hee; Oh, Kyoung-Seok; Seo, Hye-Rim; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.52 No.3, pp.945-956	view file DOI
2020-07	Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma Catenacci, Daniel V. T.; Rasco, Drew; Lee, Jeeyun; Rha, Sun Young; Lee, Keun-Wook; Bang, Yung Jue; Bendell, Johanna; Enzinger, Peter; Marina, Neyssa; Xiang, Hong; Deng, Wei; Powers, Janine; Wainberg, Zev A. Journal of Clinical Oncology, Vol.38 No.21, pp.2418-2426	DOI
2020-07	Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer Kang, Yoon-Koo; Bang, Yung-Jue; Kondo, Shunsuke; Chung, Hyun Cheol; Muro, Kei; Dussault, Isabelle; Helwig, Christoph; Osada, Motonobu; Doi, Toshihiko Clinical Cancer Research, Vol.26 No.13, pp.3202-3210	DOI
2020-08	Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial Catenacci, Daniel V. T.; Kang, Yoon-Koo; Park, Haeseong; Uronis, Hope E.; Lee, Keun-Wook; Ng, Matthew C. H.; Enzinger, Peter C.; Park, Se Hoon; Gold, Philip J.; Lacy, Jill; Hochster, Howard S.; Oh, Sang Cheul; Kim, Yeul Hong; Marrone, Kristen A.; Kelly, Ronan J.; Juergens, Rosalyn A.; Kim, Jong Gwang; Bendell, Johanna C.; Alcindor, Thierry; Sym, Sun Jin; Song, Eun-Kee; Chee, Cheng Ean; Chao, Yee; Kim, Sunnie; Lockhart, A. Craig; Knutson, Keith L.; Yen, Jennifer; Franovic, Aleksandra; Nordstrom, Jeffrey L.; Li, Daner; Wigginton, Jon; Davidson-Moncada, Jan K.; Rosales, Minori Koshiji; Bang, Yung-Jue The Lancet Oncology, Vol.21 No.8, pp.1066-1076	DOI
2020-08	S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial Kang, Yoon-Koo; Chin, Keisho; Chung, Hyun Cheol; Kadowaki, Shigenori; Oh, Sang Cheul; Nakayama, Norisuke; Lee, Keun-Wook; Hara, Hiroki; Chung, Ik-Joo; Tsuda, Masahiro; Park, Se Hoon; Hosaka, Hisashi; Hironaka, Shuichi; Miyata, Yoshinori; Ryu, Min-Hee; Baba, Hideo; Hyodo, Ichinosuke; Bang, Yung-Jue; Boku, Narikazu The Lancet Oncology, Vol.21 No.8, pp.1045-1056	DOI
2020-09	Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ) Bang, Yung-Jue; Golan, Talia; Dahan, Laetitia; Fu, Siqing; Moreno, Victor; Park, Keunchil; Geva, Ravit; De Braud, Filippo; Wainberg, Zev A.; Reck, Martin; Goff, Laura; Laing, Naomi; Mi, Gu; Oliveira, Joana M.; Wasserstrom, Heather; Lin, Chia-Chi European Journal of Cancer, Vol.137, pp.272-284	DOI
2020-09	KrAsG12C inhibition with Sotorasib in Advanced Solid Tumors Hong, David S.; Fakih, Marwan G.; Strickler, John H.; Desai, Jayesh; Durm, Gregory A.; Shapiro, Geoffrey I.; Falchook, Gerald S.; Price, Timothy J.; Sacher, Adrian; Denlinger, Crystal S.; Bang, Yung-Jue; Dy, Grace K.; Krauss, John C.; Kuboki, Yasutoshi; Kuo, James C.; Coveler, Andrew L.; Park, Keunchil; Kim, Tae Won; Barlesi, Fabrice; Munster, Pamela N.; Ramalingam, Suresh S.; Burns, Timothy F.; Meric-Bernstam, Funda; Henary, Haby; Ngang, Jude; Ngarmchamnanrith, Gataree; Kim, June; Houk, Brett E.; Canon, Jude; Lipford, J. Russell; Friberg, Gregory; Lito, Piro; Govindan, Ramaswamy; Li, Bob T. New England Journal of Medicine, Vol.383 No.13, pp.1207-1217	DOI
2020-10	Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study Marabelle, Aurelien; Fakih, Marwan; Lopez, Juanita; Shah, Manisha; Shapira-Frommer, Ronnie; Nakagawa, Kazuhiko; Chung, Hyun Cheol; Kindler, Hedy L.; Lopez-Martin, Jose A.; Miller, Wilson H., Jr.; Italiano, Antoine; Kao, Steven; Piha-Paul, Sarina A.; Delord, Jean-Pierre; McWilliams, Robert R.; Fabrizio, David A.; Aurora-Garg, Deepti; Xu, Lei; Jin, Fan; Norwood, Kevin; Bang, Yung-Jue The Lancet Oncology, Vol.21 No.10, pp.1353-1365	DOI
2020-10	Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial Shitara, Kohei; Van Cutsem, Eric; Bang, Yung-Jue; Fuchs, Charles; Wyrwicz, Lucjan; Lee, Keun-Wook; Kudaba, Iveta; Garrido, Marcelo; Chung, Hyun Cheol; Lee, Jeeyun; Castro, Hugo Raul; Mansoor, Wasat; Braghiroli, Maria Ignez; Karaseva, Nina; Caglevic, Christian; Villanueva, Luis; Goekkurt, Eray; Satake, Hironaga; Enzinger, Peter; Alsina, Maria; Benson, Al; Chao, Joseph; Ko, Andrew H.; Wainberg, Zev A.; Kher, Uma; Shah, Sukrut; Kang, S. Peter; Tabernero, Josep JAMA oncology, Vol.6 No.10, pp.1571-1580	DOI
2021-02	First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811 Chung, Hyun Cheol; Bang, Yung-Jue; S Fuchs, Charles; Qin, Shu-Kui; Satoh, Taroh; Shitara, Kohei; Tabernero, Josep; van Cutsem, Eric; Alsina, Maria; Cao, Zhu Alexander; Lu, Jia; Bhagia, Pooja; Shih, Chie-Schin; Janjigian, Yelena Y. Future Oncology, Vol.17 No.5, pp.491-501	DOI
2021-03	KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma Tabernero, Josep; Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles S.; Janjigian, Yelena Yuriy; Bhagia, Pooja; Li, Kan; Adelberg, David; Qin, Shu Kui Future Oncology, Vol.17 No.22, pp.2847-2855	DOI
2021-03	Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial Patnaik, Amita; Yap, Timothy A.; Chung, Hyun Cheol; de Miguel, Maria J.; Bang, Yung-Jue; Lin, Chia-Chi; Su, Wu-Chou; Italiano, Antoine; Chow, Kay Hoong; Szpurka, Anna M.; Yu, Danni; Zhao, Yumin; Carlsen, Michelle; Schmidt, Shelly; Vangerow, Burkhard; Gandhi, Leena; Xu, Xiaojian; Bendell, Johanna Clinical Cancer Research, Vol.27 No.5, pp.1267-1277	DOI
2021-03	Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100 Moehler, Markus; Dvorkin, Mikhail; Boku, Narikazu; Ozguroglu, Mustafa; Ryu, Min-Hee; Muntean, Alina S.; Lonardi, Sara; Nechaeva, Marina; Bragagnoli, Arinilda C.; Coskun, Hasan S.; Cubillo Gracian, Antonio; Takano, Toshimi; Wong, Rachel; Safran, Howard; Vaccaro, Gina M.; Wainberg, Zev A.; Silver, Matthew R.; Xiong, Huiling; Hong, Janet; Taieb, Julien; Bang, Yung-Jue Journal of Clinical Oncology, Vol.39 No.9, pp.966-977	DOI
2021-04	Efficacy of pembrolizumab monotherapy for advanced gastric/gastroesophageal junction cancer with programmed death ligand 1 combined positive score ≥10 Wainberg, Zev A.; Fuchs, Charles S.; Tabernero, Josep; Shitara, Kohei; Muro, Kei; Van Cutsem, Eric; Bang, Yung-Jue; Chung, Hyun Cheol; Yamaguchi, Kensei; Varga, Eniko; Chen, Jen-Shi; Hochhauser, Daniel; Thuss-Patience, Peter; Al-Batran, Salah-Eddin; Garrido, Marcelo; Kher, Uma; Shih, Chie-Schin; Shah, Sukrut; Bhagia, Pooja; Chao, Joseph Clinical Cancer Research, Vol.27 No.7, pp.1923-1931	DOI
2021-04	Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody Harding, James J.; Moreno, Victor; Bang, Yung-Jue; Hong, Min Hee; Patnaik, Amita; Trigo, Jose; Szpurka, Anna M.; Yamamoto, Noboru; Doi, Toshihiko; Fu, Siqing; Calderon, Boris; de Mendizabal, Nieves Velez; Calvo, Emiliano; Yu, Danni; Gandhi, Leena; Liu, Zhuqing Tina; Galvao, Violeta Regnier; Leow, Ching Ching; de Miguel, Maria J. Clinical Cancer Research, Vol.27 No.8, pp.2168-2178	DOI
2021-05	A target-mediated drug disposition population pharmacokinetic model of GC1118, a novel anti-EGFR antibody, in patients with solid tumors Chung, Tae Kyu; Lee, Hyun A.; Park, Sang-In; Oh, Do-Youn; Lee, Keun-Wook; Kim, Jin Won; Kim, Jee Hyun; Woo, Ahmi; Lee, Su Jin; Bang, Yung-Jue; Lee, Howard Clinical and Translational Science, Vol.14 No.3, pp.990-1001	DOI
2021-06	Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials Chao, Joseph; Fuchs, Charles S.; Shitara, Kohei; Tabernero, Josep; Muro, Kei; Van Cutsem, Eric; Bang, Yung-Jue; De Vita, Ferdinando; Landers, Gregory; Yen, Chia-Jui; Chau, Ian; Elme, Anneli; Lee, Jeeyun; Ozguroglu, Mustafa; Catenacci, Daniel; Yoon, Harry H.; Chen, Erluo; Adelberg, David; Shih, Chie-Schin; Shah, Sukrut; Bhagia, Pooja; Wainberg, Zev A. JAMA oncology, Vol.7 No.6, pp.895-902	DOI
2021-09	Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma Shitara, K.; Ozguroglu, M.; Bang, Y-J; Di Bartolomeo, M.; Mandala, M.; Ryu, M-H; Caglevic, C.; Chung, H. C.; Muro, K.; Van Cutsem, E.; Kobie, J.; Cristescu, R.; Aurora-Garg, D.; Lu, J.; Shih, C-S; Adelberg, D.; Cao, Z. A.; Fuchs, C. S. Annals of Oncology, Vol.32 No.9, pp.1127-1136	DOI
2021-11	Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 Van Cutsem, Eric; Amonkar, Mayur; Fuchs, Charles S.; Alsina, Maria; Ozguroglu, Mustafa; Bang, Yung-Jue; Chung, Hyun Cheol; Muro, Kei; Goekkurt, Eray; Benson, Al B., III; Sun, Weijing; Wainberg, Zev A.; Norquist, Josephine M.; Chen, Xinqun; Shih, Chie-Schin; Shitara, Kohei Gastric Cancer, Vol.24 No.6, pp.1330-1340	DOI
2021-11	Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors Takahashi, Shunji; Karayama, Masato; Takahashi, Masato; Watanabe, Junichiro; Minami, Hironobu; Yamamoto, Noboru; Kinoshita, Ichiro; Lin, Chia-Chi; Im, Young-Hyuck; Achiwa, Issei; Kamiyama, Emi; Okuda, Yasuyuki; Lee, Caleb; Bang, Yung-Jue Clinical Cancer Research, Vol.27 No.21, pp.5771-5780	DOI
2021-12	Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors Italiano, Antoine; Miller, Wilson H., Jr.; Blay, Jean-Yves; Gietema, Jourik A.; Bang, Yung-Jue; Mileshkin, Linda R.; Hirte, Hal W.; Higgins, Brian; Blotner, Steven; Nichols, Gwen L.; Chen, Lin Chi; Petry, Claire; Yang, Qi Joy; Schmitt, Christophe; Jamois, Candice; Siu, Lillian L. Investigational New Drugs, Vol.39 No.6, pp.1587-1597	DOI

1 2 3 4 5